MLXIX
Price
$31.23
Change
+$0.36 (+1.17%)
Updated
Jun 2 closing price
Net Assets
397.56M
OSPAX
Price
$10.61
Change
+$0.11 (+1.05%)
Updated
Jun 2 closing price
Net Assets
1.15B
Interact to see
Advertisement

MLXIX vs OSPAX

Header iconMLXIX vs OSPAX Comparison
Open Charts MLXIX vs OSPAXBanner chart's image
MLXIX vs OSPAX Comparison Chart in %
View a ticker or compare two or three
VS
MLXIX vs. OSPAX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLXIX is a Hold and OSPAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OSPAX has more cash in the bank: 1.15B vs. MLXIX (398M). OSPAX (4.80) and MLXIX (4.72) have matching dividends . MLXIX was incepted earlier than OSPAX: MLXIX (11 years) vs OSPAX (13 years). MLXIX (1.45) is less costly to investors than OSPAX (1.20). OSPAX is a more actively managed with annual turnover of: 50.00 vs. MLXIX (16.00). MLXIX has a lower initial minimum investment than OSPAX: MLXIX (2500) vs OSPAX (1000000). OSPAX annual gain was more profitable for investors over the last year : 19.24 vs. MLXIX (17.83). OSPAX return over 5 years is better than : 166.78 vs. MLXIX (140.07).
MLXIXOSPAXMLXIX / OSPAX
Total Expense Ratio1.431.20119%
Annual Report Gross Expense Ratio1.451.20121%
Fund Existence11 years13 years-
Gain YTD29.48216.692177%
Front LoadN/AN/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets398M1.15B35%
Annual Yield % from dividends4.724.8098%
Returns for 1 year17.8319.2493%
Returns for 3 years87.1099.0288%
Returns for 5 years140.07166.7884%
Returns for 10 years146.74133.49110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PW0.830.06
+7.99%
Power REIT
CWT45.341.48
+3.37%
California Water Service
NRIM24.310.27
+1.12%
Northrim BanCorp
BSAC31.110.13
+0.42%
Banco Santander-Chile
ATRA9.94-0.34
-3.31%
Atara Biotherapeutics Inc.